NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



New breast cancer study results reported from H. Neubauer et al



March 12th, 2009

According to recent research published in the journal Oncology Reports, "The expression of the estrogen receptor beta (ER beta) has been shown to play an important role in breast cancer. There is emerging hope that ER beta and its isoforms will be used as prognostic markers or as therapeutic targets in the clinical management of breast cancer."

"Many studies indicate that ER beta is down regulated during carcinogenesis. However, it is still unknown which signals can regulate ER beta expression. Basement membrane (BM) components have been shown to influence the expression levels of ER alpha and progesterone receptor. Therefore, we hypothesized that cell-matrix...


Source: Women's Health Weekly (2009-03-12)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login